|
1
|
Ogawa R, Dohi T, Tosa M, Aoki M and
Akaishi S: The latest strategy for keloid and hypertrophic scar
prevention and treatment: The Nippon medical school (NMS) Protocol.
J Nippon Med Sch. 88:2–9. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bi M, Sun P, Li D, Dong Z and Chen Z:
Intralesional injection of botulinum toxin type A compared with
intralesional injection of corticosteroid for the treatment of
hypertrophic scar and keloid: A systematic review and
meta-analysis. Med Sci Monit. 25:2950–2958. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nischwitz SP, Fink J, Schellnegger M, Luze
H, Bubalo V, Tetyczka C, Roblegg E, Holecek C, Zacharias M, Kamolz
LP and Kotzbeck P: The role of local inflammation and hypoxia in
the formation of hypertrophic scars-a new model in the Duroc pig.
Int J Mol Sci. 24(316)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Paish HL, Kalson NS, Smith GR, Del Carpio
Pons A, Baldock TE, Smith N, Swist-Szulik K, Weir DJ, Bardgett M,
Deehan DJ, et al: Fibroblasts promote inflammation and pain via
IL-1α induction of the monocyte chemoattractant chemokine (C-C
Motif) ligand 2. Am J Pathol. 188:696–714. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hedayatyanfard K, Haddadi NS, Ziai SA,
Karim H, Niazi F, Steckelings UM, Habibi B, Modarressi A and
Dehpour AR: The renin-angiotensin system in cutaneous hypertrophic
scar and keloid formation. Exp Dermatol. 29:902–909.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li J, Wang J, Wang Z, Xia Y, Zhou M, Zhong
A and Sun J: Experimental models for cutaneous hypertrophic scar
research. Wound Repair Regen. 28:126–144. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bahrami M, Haji Molla Hoseini M, Rezaei M
and Ziai SA: Umbelliprenin increases the M1/M2 ratio of macrophage
polarization and improves the M1 macrophage activity in THP-1 cells
cocultured with AGS cells. Evid Based Complement Alternat Med.
2021(9927747)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang HT, Han JT and Hu DH: Research
advances on the role and mechanism of inflammatory response in the
formation of hypertrophic scars and keloids. Zhonghua Shao Shang Za
Zhi. 37:490–494. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
9
|
Weber KJ, Sauer M, He L, Tycksen E,
Kalugotla G, Razani B and Schilling JD: PPARγ deficiency suppresses
the release of IL-1β and IL-1α in macrophages via a type 1
IFN-dependent mechanism. J Immunol. 201:2054–2069. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Barone N, Safran T, Vorstenbosch J,
Davison PG, Cugno S and Murphy AM: Current advances in hypertrophic
scar and keloid management. Semin Plast Surg. 35:145–152.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lei JA, Zhou Y and Qin ZL: Research
advances on inflammatory responses involved in keloid development.
Zhonghua Shao Shang Za Zhi. 37:591–595. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
12
|
Ogawa R: The most current algorithms for
the treatment and prevention of hypertrophic scars and keloids: A
2020 update of the algorithms published 10 years ago. Plast
Reconstr Surg. 149:79e–94e. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bojanic C, To K, Hatoum A, Shea J, Seah
KTM, Khan W and Malata CM: Mesenchymal stem cell therapy in
hypertrophic and keloid scars. Cell Tissue Res. 383:915–930.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lee HJ and Jang YJ: Recent understandings
of biology, prophylaxis and treatment strategies for hypertrophic
scars and keloids. Int J Mol Sci. 19(711)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Frech FS, Hernandez L, Urbonas R, Zaken
GA, Dreyfuss I and Nouri K: Hypertrophic scars and keloids:
Advances in treatment and review of established therapies. Am J
Clin Dermatol. 24:225–245. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Knowles A and Glass DA II: Keloids and
hypertrophic scars. Dermatol Clin. 41:509–517. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Le X and Wu WW: The therapeutic effect of
Interleukin-18 on hypertrophic scar through inducing Fas ligand
expression. Burns. 47:430–438. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wei J, Wang Z, Zhong C, Ding H, Wang X and
Lu S: LncRNA MIR503HG promotes hypertrophic scar progression via
miR-143-3p-mediated Smad3 expression. Wound Repair Regen.
29:792–800. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang D, Li B and Zhao M: Therapeutic
strategies by regulating interleukin family to suppress
inflammation in hypertrophic scar and keloid. Front Pharmacol.
12(667763)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shi J, Shi S, Xie W, Zhao M, Li Y, Zhang
J, Li N, Bai X, Cai W, Hu X, et al: IL-10 alleviates
lipopolysaccharide-induced skin scarring via IL-10R/STAT3 axis
regulating TLR4/NF-κB pathway in dermal fibroblasts. J Cell Mol
Med. 25:1554–1567. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen J, Zhou R, Liang Y, Fu X, Wang D and
Wang C: Blockade of lncRNA-ASLNCS5088-enriched exosome generation
in M2 macrophages by GW4869 dampens the effect of M2 macrophages on
orchestrating fibroblast activation. FASEB J. 33:12200–12212.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu X, Gu S, Huang X, Ren J, Gu Y, Wei C,
Lian X, Li H, Gao Y, Jin R, et al: The role of macrophages in the
formation of hypertrophic scars and keloids. Burns Trauma.
8(tkaa006)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li T, Chen W, Zhang Q and Deng C:
Human-specific gene CHRFAM7A mediates M2 macrophage polarization
via the Notch pathway to ameliorate hypertrophic scar formation.
Biomed Pharmacother. 131(110611)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wilgus TA: Vascular endothelial growth
factor and cutaneous scarring. Adv Wound Care (New Rochelle).
8:671–678. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Apte RS, Chen DS and Ferrara N: VEGF in
signaling and disease: Beyond discovery and development. Cell.
176:1248–1264. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qi X, Liu Y and Yang M: Circ_0057452
functions as a ceRNA in hypertrophic scar fibroblast proliferation
and VEGF expression by regulating TGF-β2 expression and adsorbing
miR-145-5p. Am J Transl Res. 13:6200–6210. 2021.PubMed/NCBI
|
